ACHE-IN-38

CAS No. 120014-30-4

ACHE-IN-38( —— )

Catalog No. M37278 CAS No. 120014-30-4

ACHE-IN-38 is a potent Acetylcholinesterase inhibitor that can be used for the synthesis of compounds with anti-inflammatory, anti-tumor, and antibacterial activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 Get Quote
10MG 67 Get Quote
25MG 104 Get Quote
50MG 150 Get Quote
100MG 215 Get Quote
500MG 530 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ACHE-IN-38
  • Note
    Research use only, not for human use.
  • Brief Description
    ACHE-IN-38 is a potent Acetylcholinesterase inhibitor that can be used for the synthesis of compounds with anti-inflammatory, anti-tumor, and antibacterial activities.
  • Description
    ACHE-IN-38 is a potent Acetylcholinesterase inhibitor that can be used for the synthesis of compounds with anti-inflammatory, anti-tumor, and antibacterial activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antifungal
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    120014-30-4
  • Formula Weight
    289.37
  • Molecular Formula
    C17H23NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2CC(CC3CCNCC3)C(=O)c2cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Potassium acetate

    Potassium acetate with antibacterial and antifungal properties.

  • LW3

    LW3 is an effective broad-spectrum antifungal compound. LW3 showed antifungal activity against B. cinerea, R. solani, S. sclerotiorum and F. graminearum, with EC50 values of 0.54, 0.09, 1.52 and 2.65 mg/L, respectively.

  • Asebogenin

    Asebogenin is a compound fractionated from Salvia miltiorrhiza with antifungal activity, inhibition of GPVI-induced platelet reactions, and inhibition of NET formation induced by pro-inflammatory stimuli.